Industry Speaks II: Adynamic Bone Disease: What It is, What Are Its Consequences and What You Can Do About It

Industry Speaks II: Adynamic Bone Disease: What It is, What Are Its Consequences and What You Can Do About It

$9.95
{{option.name}}: {{selected_options[option.position]}}
{{value_obj.value}}

Adynamic Bone Disease - Histology, Consequences, and Treatment - Hartmut Malluche, MD The Biochemistry of the 7-84 PTH Molecule - Thomas L. Cantor, BA Adynamic Bone Disease Begins before Dialysis - Akihide Tokumoto, MD High iPTH & Low Ratio Indicate Adynamic Bone Disease - Victor Rozas, MD Panel Discussion: Tom Cantor, BA, Hartmut Malluche, MD, Victor Rozas, MD & Akihide Tokumoto, MD Adjourn

Show More Show Less